FBT vs. HELX
Compare and contrast key facts about First Trust Amex Biotechnology Index (FBT) and Franklin Genomic Advancements ETF (HELX).
FBT and HELX are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FBT is a passively managed fund by First Trust that tracks the performance of the NYSE Arca Biotechnology Index. It was launched on Jun 23, 2006. HELX is an actively managed fund by Franklin Templeton. It was launched on Feb 25, 2020.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBT or HELX.
Key characteristics
| FBT | HELX | |
|---|---|---|
| YTD Return | -8.95% | -1.33% |
| 1Y Return | -6.97% | -0.03% |
| 3Y Return (Ann) | -3.87% | -13.28% |
| Sharpe Ratio | -0.36 | 0.04 |
| Daily Std Dev | 17.48% | 17.19% |
| Max Drawdown | -40.51% | -56.33% |
| Current Drawdown | -21.07% | -48.24% |
Correlation
The correlation between FBT and HELX is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FBT vs. HELX - Performance Comparison
In the year-to-date period, FBT achieves a -8.95% return, which is significantly lower than HELX's -1.33% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBT vs. HELX - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than HELX's 0.50% expense ratio.
Risk-Adjusted Performance
FBT vs. HELX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBT vs. HELX - Dividend Comparison
Neither FBT nor HELX has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% | 0.05% |
HELX Franklin Genomic Advancements ETF | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
FBT vs. HELX - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, smaller than the maximum HELX drawdown of -56.33%. Use the drawdown chart below to compare losses from any high point for FBT and HELX. For additional features, visit the drawdowns tool.
Volatility
FBT vs. HELX - Volatility Comparison
The current volatility for First Trust Amex Biotechnology Index (FBT) is 5.30%, while Franklin Genomic Advancements ETF (HELX) has a volatility of 5.89%. This indicates that FBT experiences smaller price fluctuations and is considered to be less risky than HELX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.